Yüklüyor......
Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections
Thirty-seven carbapenem-resistant Enterobacteriaceae (CRE)-infected patients were treated with ceftazidime-avibactam. Clinical success and survival rates at 30 days were 59% (22/37) and 76% (28/37), respectively. In 23% (5/22) of clinical successes, CRE infections recurred within 90 days. Microbiolo...
Kaydedildi:
| Yayımlandı: | Clin Infect Dis |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5146720/ https://ncbi.nlm.nih.gov/pubmed/27624958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw636 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|